Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Chronic Lymphocytic Leukemia
3:19
Safety and efficacy of LV20.19 CAR-T therapy in Richter’s transformation and R/R MCL
Nirav Shah
• 15 Feb 2023
8:25
CAR-T therapy in acute and chronic leukemias: current applications and future outlooks
John Gribben
• 10 Feb 2023
3:58
Results from the first-in-human trial of huCART19-IL18 in patients with R/R NHL and CLL
Jakub Svoboda
• 11 Dec 2022
3:30
Second CD19-targeted CAR T-cell infusion for R/R B-cell malignancies
Jordan Gauthier
• 28 Jan 2021
8:17
CART19-BE-01: ARI-0001 in CD19+ malignancies
Valentín Ortiz-Maldonado
• 11 Oct 2020
4:51
Anti-CD19 CAR T-cells for adults
David L. Porter
• 9 Sep 2020
5:25
Long-term outcomes of anti-CD19 CAR-T in R/R CLL
David L. Porter
• 16 Sep 2020
